Therapy of parkinsonism
Paal, G.
Die Medizinische Welt 24(15): 573-576
1973
ISSN/ISBN: 0025-8512 PMID: 4744982 Document Number: 66127
Document emailed within 1 workday
Related Documents
Pakkenberg, H. 1973: Amantadine therapy in parkinsonism Ugeskrift for Laeger 135(3): 135-136Jörg, J. 1975: Therapy of parkinsonism using L-Dopa (Brocadopa) Die Medizinische Welt 26(3): 124-126
Bhaskar, P.A.; Bhaskar, E.A.; Jagannathan, K. 1975: Augmenting procedures during L-dopa therapy for Parkinsonism Journal of the Association of Physicians of India 23(1): 21-27
Ajuriaguerra, J.; Gauthier, G.; Geissbuhler, F.; Simona, B.; Constantinidis, J.; Yanniotis, G.; Krassoievitch, M.; Eisenring, J.; Tissot, R. 1971: Substitution therapy of parkinsonism. Insufficient results with 3-0-methyldopa La Presse Medicale 79(30): 1396
Stammler, A.; Vielhaber, K. 1972: Therapy of Parkinsonism using L-dopa in combination with a decarboxylase inhibitor Fortschritte der Neurologie Psychiatrie und Ihrer Grenzgebiete 40(10): 564-568
Marjerrison, G.; Boulton, A.A.; Rajput, A. 1971: Dopa therapy in parkinsonism effects on the EEG and amine metabolism Internationale Zeitschrift für Klinische Pharmakologie Therapie und Toxikologie. International Journal of Clinical Pharmacology Therapy and Toxicology 4(2): 263-266
Yahr, M.D.; Duvoisin, R.C.; Mendoza, M.R.; Schear, M.J.; Barrett, R.E. 1971: Modification of L-dopa therapy of Parkinsonism by alpha-methyldopa hydrazine (MK-486) Transactions of the American Neurological Association 96: 55-58
Keenan, R.E. 1970: The Eaton collaborative study of levodopa therapy in parkinsonism: a summary Neurology 20(12): Suppl: 46-65
Eisenlohr, J.J.; Gehlen, W. 1979: Quantitative measurement of muscle tone in patients with Parkinsonism before and during therapy with madopar Fortschritte der Neurologie Psychiatrie und Ihrer Grenzgebiete 47(7): 331-346
Mizoi, Y.; Kaneko, H.; Oharazawa, A.; Kuroiwa, H. 1997: Parkinsonism in a patient receiving interferon alpha therapy for chronic hepatitis C Rinsho Shinkeigaku 37(1): 54-56
Shoulson, I. 1983: Carbidopa/levodopa therapy of coexistent drug-induced parkinsonism and tardive dyskinesia Advances in Neurology 37: 259-266
Sigwald, J.; Raymondeaud, C.; Piot, C. 1973: Method for appraisal and measurement of extrapyramidal symptoms and signs. Clinical evaluation of Parkinsonism. Value in the evaluation of severeness, in the estimation of the evolutive potential, in the appreciation as strict as possible of the effectiveness of antiparkinson therapy La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 49(10): 693-704
Watson, J. 1976: Parkinsonism Nursing Mirror and Midwives Journal 142(13): 50-51
Kase, M. 1970: Parkinsonism Nihon Rinsho. Japanese Journal of Clinical Medicine 28(3): 546-550
Togi, H. 1977: Parkinsonism Nihon Rinsho. Japanese Journal of Clinical Medicine 35(Suppl 1): 566-567
Reveno, W.S.; Bauer, R.B.; Rosenbaum, H. 1973: L-dopa for parkinsonism Geriatrics 28(1): 86-88
Leibowitz, U.; Feldman, S. 1973: Age shift in parkinsonism Israel Journal of Medical Sciences 9(5): 599-602
Yahr, M.D. 1987: R-(-)-deprenyl and parkinsonism Journal of Neural Transmission. Supplementum 25: 5-12
Flatberg, P. 1970: 1-dopa for parkinsonism Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 90(10): 1102-1103
Mori, H. 1999: Postencephalitic parkinsonism Ryoikibetsu Shokogun Shirizu 1999(27 Pt 2): 32-35